Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science. This funding underscores investor confidence in Vektor’s vision and ability to successfully execute its mission to revolutionize arrhythmia care.
Data from the first US comprehensive single center experience at St Bernard’s Medical Center and Arrhythmia Research Group, presented at a Late-Breaking session at the AF Symposium 2024 in Boston, shows that Left Atrial Appendage Occlusion (LAAO) procedures planned by means of FEops HEARTguideTM result in significantly improved procedural efficiency.
Australia has laid out an ambitious "10-year Digital Health Blueprint" aimed at rei…
Amazon's pioneering pilot program is reshaping healthcare as it seamlessly integrat…
Jakarta-based healthtech startup, Klinik Pintar, has secured a significant boost of…
Sehat Kahani, a groundbreaking health-tech startup led by women, has announced the …
Oita University and Eisai Co., Ltd. have achieved a groundbreaking milestone in the…
Let's take a look back at the most intriguing updates I've shared this month on inn…
New study* reveals greater comprehension and personal engagement with enhanced e-consentPALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, announces results from a new research project with Du...
Manifest MedEx (MX), California’s largest nonprofit Qualified Health Information Organization (QHIO), is launching the California ADT Network — a no-cost, electronic ADT notification exchange — to help organizations exchange ADT data in compliance with the DxF and to substantially scale the sharing of ADT alerts across the state.